Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study

Tocilizumab versus baricitinib in hospitalized patients with

IJMS, Free Full-Text

Post-COVID-19 interstitial lung disease presenting with profound

Coronavirus COVID-19 (SARS-CoV-2)

JCM, Free Full-Text

Frontiers Efficacy and safety of tocilizumab and baricitinib

Cureus From Emergence to Endemicity: A Comprehensive Review of

Tocilizumab in Hospitalized Patients with Severe Covid-19

Triple immune modulator therapy for aberrant hyperinflammatory

Pharmaceuticals, Free Full-Text

A systematic review and meta-analysis of Anakinra, Sarilumab

Role of baricitinib in COVID-19 patients: A systematic review and

The signal pathways and treatment of cytokine storm in COVID-19

The signal pathways and treatment of cytokine storm in COVID-19

Frontiers Tocilizumab and COVID-19: Timing of Administration and